SGHT Sight Sciences, Inc.
$8.14▲ +1.69%
Healthcare
Other
After hours
$8.17▲ +0.35%
Sep 11, 5:46 PM ET
Volume 179.6K
Avg Volume (10D) 159.1K
Key Metrics & Fundamentals
Market Cap
$448.42M
P/E Ratio
–
Div Yield
–%
52W Range
3.19 - 9.24
% vs 50 MA
20.44%
% vs 200 MA
38.64%
RSI-14
59.3
MACD Histogram
-0.1500
Beta (1Y vs SPY)
1.83
Free Cash Flow
-$5.68M
Gross Rev
$23.39M
Gross Profit
$21.37M
EBITDA
-$3.71M
COGS
$2.01M
Operating Exp
$25.26M
Operating Income
-$3.89M
EBIT
-$3.89M
Pretax Income
-$4.42M
Net Income
-$4.45M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15
GlobeNewswire · Sep 1, 2026 8:05 PM
Sector Update: Healthcare Stocks Gain Late Afternoon
MT Newswires · Aug 19, 2026 7:50 PM
Sector Update: Healthcare Stocks Gain Wednesday Afternoon
MT Newswires · Aug 19, 2026 5:26 PM
Sector Update: Healthcare Stocks Higher in Wednesday Trading
MT Newswires · Aug 19, 2026 1:43 PM
Sight Sciences Gets US FDA Label Expansion for TearCare Dry Eye Treatment
MT Newswires · Aug 19, 2026 11:45 AM
TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease
GlobeNewswire · Aug 19, 2026 11:05 AM
Sight Sciences (SGHT) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 12, 2026 11:29 PM
UBS Adjusts Price Target on Sight Sciences to $8 From $7, Maintains Buy Rating
MT Newswires · Aug 6, 2026 2:47 PM
Sight Sciences Inc (SGHT) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and Raised ...
GuruFocus.com · Aug 6, 2026 5:08 AM
Sight Sciences Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 5:03 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See SGHT's money flow as a full page
Social Sentiment
No Reddit posts found for SGHT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.